Financiere Des Professionnels Fonds D,Investissement Inc. Gilead Sciences, Inc. Transaction History
Financiere Des Professionnels Fonds D,Investissement Inc.
- $1.66 Trillion
- Q2 2025
A detailed history of Financiere Des Professionnels Fonds D,Investissement Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Financiere Des Professionnels Fonds D,Investissement Inc. holds 32,948 shares of GILD stock, worth $3.97 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
32,948
Previous 1,000
3194.8%
Holding current value
$3.97 Million
Previous $112 Million
3160.1%
% of portfolio
0.22%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
2,297Shares Held
1BCall Options Held
9.46MPut Options Held
9.94M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.5MShares$7.17 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.58 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.45 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $151B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...